Ljungman, P., Bermudez, A., Logan, A. C., Kharfan-Dabaja, M. A., Chevallier, P., Martino, R., Wulf, G., Selleslag, D., Kakihana, K., Langston, A., Lee, D., Solano, C., Okamoto, S., Smith, L. R., Boeckh, M., Wingard, J. R., Cywin, B., Fredericks, C., Lademacher, C., Wang, X., Young, J., & Maertens, J. (2021). a randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients. EClinicalMedicine, 33, . http://access.bl.uk/ark:/81055/vdc_100124364240.0x000004